Grace Therapeutics (GRCE) Times Interest Earned (2019)

Grace Therapeutics' (GRCE) quarterly Times Interest Earned came in at 267.22 in Q4 2019, down 28.16% quarter-over-quarter from 208.5 in Q3 2019.

Analysis

Grace Therapeutics (GRCE) Times Interest Earned (2019) Analysis & Trends

Grace Therapeutics has disclosed Times Interest Earned across 1 years of filings, most recently posting 267.22 for Q4 2019.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Johnson & Johnson	642.60 Bn	621.84 Bn	17.26 Bn	25.41
2	AbbVie	447.11 Bn	440.55 Bn	12.70 Bn	-
3	Merck	358.25 Bn	351.11 Bn	12.21 Bn	-
4	Novartis Ag	267.57 Bn	259.88 Bn	11.24 Bn	10.28
5	Pfizer	156.64 Bn	144.94 Bn	10.94 Bn	-
6	Sanofi	52.20 Bn	44.82 Bn	10.79 Bn	3.65
7	Revolution Medicines	42.91 Bn	42.91 Bn	-	-21.24
8	Incyte	24.64 Bn	20.11 Bn	1.57 Bn	1,199.14
9	United Therapeutics	21.56 Bn	18.90 Bn	683.80 Mn	114.07
10	Grace Therapeutics	38.65 Mn	38.65 Mn	-	-

Historic Data

Download Data